Altimmune, Inc. (ALT) Tops Q1 EPS by 12c
Tweet
Share
E-mailGet Alerts ALT Hot Sheet
Join SI Premium – FREE
Altimmune, Inc. (NASDAQ: ALT) reported Q1 EPS of ($0.26), $0.12 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $5 thousand.
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stay long AI-capex winners into the peak, Stifel says despite bubble fears
- Freshpet co-founder Morris to step back as Baty takes president role
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
